Leading ALD Provider Listed on Deloitte's Finnish Technology Fast 50 Program

Beneq, leading provider of industrial thin film equipment and technology based on atomic layer deposition (ALD) and aerosol coating, has been listed by Deloitte's Finnish Technology Fast 50 program. The program is a ranking of the country's 50 fastest-growing technology companies based on percentage revenue growth over a five-year period.

The Technology Fast 50 program, which is part of Deloitte Technology, Media & Telecommunications, was established in 1995 and ranks the 50 fastest growing technology companies by geographic region. The program operates independently today in 18 countries and one region. This year was the sixth time the competition was arranged in Finland. Of all participants in the ranking, Beneq came in tenth with a growth percentage of 1090%.

In the words of Beneq CEO Sampo Ahonen: "This prize is, as is all recognition for hard work and success, a great motivator to push forward, to achieve more and to let it show. We are very proud to be on the Technology Fast 50 list, and we take this recognition as a definite sign of our growth strategy being the right one. We also see this prize as one further reason for our customers to know they are dealing with a reliable company that can really fulfil their needs, both in research and industrial production.

To conclude, I would like to emphasize, that a trophy of this kind is an acknowledgement addressed not only to Beneq alone, but also to the whole community of partners and collaborators that surrounds us. Without the input of our friends, we would not be where we are today."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.